Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-03

Clinical Trial Update: Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD [Phase 4]

View source ↗

Summary

Phase 4 trial investigating curcumin therapy for vascular dysfunction in Autosomal Dominant Polycystic Kidney Disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Polycystic Kidney, Autosomal Dominant | Phase 4 | Status: COMPLETED | Results posted: 2022-03-03